Results 61 to 70 of about 148,412 (201)

PROSTATE-SPECIFIC ANTIGEN AND ITS MOLECULAR FORMS IN BLOOD SERUM OF HEALTHY WOMEN AND WOMEN WITH BREAST DISEASE

open access: yesСибирский онкологический журнал, 2020
The purpose of the study was to provide data on the sources of prostate-specific antigen (Psa) in women, as well as on serum Psa levels in healthy women and in women with benign and malignant breast cancer. Material and methods.
N. S. Sergeeva   +5 more
doaj   +1 more source

The Abuse and Cost of Free PSA

open access: yesUrology Research and Practice, 2019
-
N.A. ERÖZENCİ   +5 more
doaj   +2 more sources

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer. [PDF]

open access: yes, 2018
Purpose: Molecular characterization of prostate cancer, including The Cancer Genome Atlas, has revealed distinct subtypes with underlying genomic alterations.
Alshalalfa, Mohammed   +17 more
core   +1 more source

Primary goals, information-giving and men\u27s understanding: A qualitative study of Australian and UK doctors\u27 varied communication about PSA screening [PDF]

open access: yes, 2017
Objectives: (1) To characterise variation in general practitioners’ (GPs’) accounts of communicating with men about prostate cancer screening using the prostate-specific antigen (PSA) test, (2) to characterise GPs’ reasons for communicating as they do ...
Carter, Stacy M   +4 more
core   +3 more sources

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer

open access: yesمجله دانشکده پزشکی اصفهان, 2013
Background: One of the most common visceral cancers among men in the world is prostate cancer. Screening for early detection has a positive effect on patients’ survival time.
Mohammad Yazdani   +3 more
doaj  

Efficacy and Prognostic Factors of Docetaxel Rechallenge on Metastatic Castration-resistant Prostate Cancer Patients

open access: yesZhongliu Fangzhi Yanjiu, 2019
Objective To assess the efficacy of docetaxel rechallenge on castration-resistant prostate cancer (mCRPC) patients and to analyze prognostic factors. Methods We retrospectively reviewed the medical history of 120 mCRPC patients treated with the first ...
DUAN Liqun   +4 more
doaj   +1 more source

Synthetic DNA immunotherapy in biochemically relapsed prostate cancer [PDF]

open access: yes, 2018
Background: INO-5150 (PSA and PSMA) +/- INO-9012 (IL-12), a synthetic DNA immunotherapy, was assessed for safety, immunogenicity and efficacy in biochemically recurrent prostate cancer patients (pts).
Appleman, L. J.   +19 more
core   +1 more source

The Impact of Intraoperative Manipulation of the Prostate on Total and Free Prostate-Specific Antigen

open access: yesThe International Journal of Biological Markers, 2002
Objectives It is well documented that mechanical manipulation of the prostate can elevate total PSA (t-PSA) levels in serum. However, less is known about its effects on free PSA (f-PSA) and the free-to-total PSA ratio (f/t-PSA). We therefore examined the
F. Oberpenning MD   +4 more
doaj   +1 more source

PSA AND FREE PSA LEVELS OF PATIENTS WITH BREAST, UTERUS AND OVER CANCER

open access: yesUrology Research and Practice, 2019
-
M. HACIBEKİROĞLU   +3 more
doaj   +2 more sources

The effect of urethral catheterization on the level of prostate-specific antigen

open access: yesJournal of Research in Medical Sciences, 2017
Background: The normal prostate-specific antigen (PSA) level in patients with urethral catheterization is a controversy. We designed this study to investigate the effect of nontraumatic urethral catheterization without urinary retention on serum PSA ...
Mohammad Hossein Izadpanahi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy